Prostate Cancer and Pancreatic Cancer: New Studies Indicate Improvement with PC Hope
Studies show that for people with pancreatic cancer and men with prostate cancer, PC Hope is associated with significant improvements in quality of life, reductions in patients’ pain rating, and a decline in PSA levels for prostate cancer patients—all without major side effects.
(PRWEB) December 9, 2004 -- PC Hope, an herbal supplement from Nutrition
2000, has not only shown significant improvement for prostate cancer patients, but also has shown antiproliferative
and apoptotic (cell death) effects with pancreatic cancer.
In a pancreatic cancer study, eight human pancreatic cancer cell
lines were exposed to PC Hope. Cell proliferation effects on the cell cycle and
the mode of cell death were analyzed. In vivo effects were also studied in an
intraperitoneal mouse model. PC Hope displayed inhibition of cell growth in all
eight pancreatic cancer lines. Three-hour exposure to PC Hope led to a
significant absolute increase in the cell cycle fraction. Cyclin B1 levels were
downregulated in all pancreatic cancer cell lines after 24 hour exposure to PC
Hope. After 24 hours of PC Hope exposure DAPI positive apoptotic nuclear
formations were seen in 20% to 46% of pancreatic cancer cells. The studies
ultimately showed that PC Hope mediates powerful and deadly effects against an
array of pancreatic cancer cells. In vivo activity has led to a significant
survival advantage, but no curative prognosis to date. PC Hope’s promising
remedy for pancreatic cancer, qualifies for phase I clinical testing.
With the cancer as a leading cause of death in the United States, Nutrition 2000
is truly optimistic.
The prostate